Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

National Enzyme buys Sora Laboratories

This article was originally published in The Tan Sheet

Executive Summary

The Forsyth, Mo.-based dietary supplement developer improves its ability to identify raw materials and test their quality and potency in-house with the acquisition of Sora Laboratories. The 600-square-foot full-service, analytical, microbiological and characteristics lab includes instruments to conduct detailed tests and in-depth analyses, National Enzyme Co. announced July 2. "With questionable raw material suppliers existing and adulterated products popping up, it is essential for a manufacturer to have the ability to accurately identify all that passes through their doors," the firm says. The firm intends to become ISO certified by fall 2010

You may also be interested in...



The Cost Of Coronavirus: Medtech Market Wins And Losses

With the rapid global spread of the coronavirus, Medtech Insight looks at the predicted economic impact of the outbreak on the industry’s biggest businesses.

Yes For Shionogi But No For Lilly In Latest EMA Recommendations

The European Medicines Agency says that Shionogi’s novel antibiotic, Fetcroja, should be approved for use across Europe but that Lilly's migraine drug, Emgality, should not be authorized for the extended indication of episodic cluster headache.

UK To Seek Only Limited Regulatory Alignment With EU

Despite the life sciences industry’s call for continued alignment of medicines regulation with the EU from next year and for some sort of co-operation with the European Medicines Agency, it seems the UK government is prepared to make only small concessions.

Topics

UsernamePublicRestriction

Register

PS104294

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel